Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme -- preventing or reducing organ and central nervous system damage from the often-fatal genet ...
Source:
Cincinnati Children's Hospital Medical Center
Monday, November 9, 2009